ramucirumab-IR700 conjugate (Jikei University School of Medicine)

N/A

Report date: 2025/03/20 10:01:15

Base Information

Drug Nameramucirumab-IR700 conjugate (Jikei University School of Medicine)

Drug Alias NameVEGFR2-targeted photoimmunotherapy (Jikei University School of Medicine)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonists

TargetsVascular endothelial growth factor receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJikei University

China Registration ClassN/A

Develop Information

Active CompaniesJikei University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A